ICU Medical ICUI
$172.52 −$3.24 (-1.84%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $172.52 0.00%
Open$177.17
Prev close$175.76
Day range$171.40 – $178.52
Volume223.4K
Market cap$4.31B
P/E (TTM)72.2
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$560.44M+4.4% YoY
Operating profit$58.59M+118.2% YoY
Net profit$26.85M+890.5% YoY
Diluted EPS$1.07+864.3% YoY
Free cash flow$81.71M+227.4% YoY
Operating cash flow$99.59M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin40.3%
Operating margin8.0%
Net margin2.8%
Return on equity2.8%
Return on assets1.5%
Return on invested capital2.9%
Current ratio2.37
Liabilities / assets44.4%
Cash & investments$301.78M
Total debt$1.19B
Net cash (debt)-$889.94M
Free cash flow / sales9.2%
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $560.44M | $551.68M | $530.23M | $2.23B | $540.70M |
| Total Operating Revenue | $560.44M | $551.68M | $530.23M | $2.23B | $540.70M |
| Cost of Revenue | $325.69M | $316.63M | $324.00M | $1.41B | $337.72M |
| Gross Profit | $234.75M | $235.05M | $206.23M | $822.04M | $202.99M |
| Operating Expense | $176.16M | $174.62M | $175.85M | $712.71M | $176.90M |
| Selling and Admin Expenses | $154.41M | $151.92M | $154.57M | $625.21M | $155.81M |
| Research & Development | $21.75M | $22.70M | $21.28M | $87.50M | $21.09M |
| Operating Profit | $58.59M | $60.43M | $30.38M | $109.33M | $26.09M |
| Net Non-Operating Interest Income (Expense) | -$15.24M | -$15.75M | -$16.49M | -$83.03M | -$20.64M |
| Non-Operating Interest Income | $2.86M | $2.81M | $2.04M | $10.31M | $2.14M |
| Non-Operating Interest Expense | $18.10M | $18.56M | $18.53M | $93.34M | $22.78M |
| Other Income (Expense) | -$7.17M | -$21.54M | -$17.86M | -$21.95M | -$21.35M |
| Gain on Sale of Security | -$423,000.00 | -$853,000.00 | -$908,000.00 | $3.79M | $1.82M |
| Special Income (Charges) | -$7.10M | -$21.87M | -$16.94M | -$26.08M | -$23.13M |
| -Less:Restructuring and Mergern & Acquisition | $6.27M | $21.30M | $16.80M | $66.51M | $20.45M |
| -Less:Write Off | $2.83M | – | – | – | – |
| -Gain on Sale Of Business | $2.24M | $0.00 | – | $44.79M | $0.00 |
| -Gain on Sale of Property/Plant/Equipment | -$232,000.00 | -$567,000.00 | -$135,000.00 | -$4.37M | -$2.68M |
| Other Non-Operating Income (Expenses) | $345,000.00 | $1.18M | -$17,000.00 | $348,000.00 | -$32,000.00 |
| Pretax Profit | $36.18M | $23.14M | -$3.98M | $4.36M | -$15.90M |
| Tax | $7.19M | $7.07M | -$34.71M | $2.44M | -$2.65M |
| $2.14M | -$3.01M | $607,000.00 | $1.19M | $2.49M | |
| Net Profit | $26.85M | $19.09M | $30.13M | $732,000.00 | -$15.73M |
| Profit from Continuing Operations | $26.85M | $19.09M | $30.13M | $732,000.00 | -$15.73M |
| Net Income to Parent Company | $26.85M | $19.09M | $30.13M | $732,000.00 | -$15.73M |
| Net Income to Common Stockholders | $26.85M | $19.09M | $30.13M | $732,000.00 | -$15.73M |
| Basic EPS | $1.07 | $0.76 | $1.22 | $0.03 | -$0.64 |
| Diluted EPS | $1.07 | $0.76 | $1.20 | $0.03 | -$0.64 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $3.94B | $3.97B | $4.01B | $4.05B | $4.05B |
| Total Current Assets | $1.22B | $1.21B | $1.21B | $1.19B | $1.19B |
| Cash and Cash Equivalents & Short-Term Investments | $301.78M | $298.30M | $288.33M | $307.96M | $307.96M |
| -Cash and Cash Equivalents | $301.78M | $298.30M | $288.33M | $307.96M | $307.96M |
| Receivables | $236.97M | $218.64M | $226.82M | $203.91M | $203.91M |
| -Accounts Receivable | $206.26M | $183.53M | $201.08M | $180.52M | $180.52M |
| -Taxes Receivable | $10.75M | $10.36M | – | – | – |
| -Other Receivables | $19.97M | $24.75M | $25.74M | $23.39M | $23.39M |
| Prepaid Assets | $22.98M | $25.45M | $24.23M | $25.47M | $25.47M |
| Inventory | $607.27M | $607.42M | $605.59M | $615.86M | $615.86M |
| Current Deferred Assets | $26.34M | $21.46M | $24.26M | $13.11M | $13.11M |
| Other Current Assets | $24.53M | $34.35M | $38.61M | $20.50M | $20.50M |
| Total Non-Current Assets | $2.72B | $2.76B | $2.80B | $2.86B | $2.86B |
| Net PPE | $481.16M | $485.41M | $495.93M | $511.89M | $511.89M |
| -Gross PPE | $1.17B | $1.16B | $1.16B | $1.16B | $1.16B |
| -Accumulated Depreciation | -$690.29M | -$675.61M | -$660.72M | -$645.91M | -$645.91M |
| Investments and Advances | $128.93M | $133.91M | $130.92M | $131.59M | $131.59M |
| -Long Term Equity Investment | $128.93M | $133.91M | $130.92M | $131.59M | $131.59M |
| Goodwill and Other Intangible Assets | $2.02B | $2.05B | $2.08B | $2.13B | $2.13B |
| -Goodwill | $1.48B | $1.48B | $1.49B | $1.50B | $1.50B |
| -Other Intangible Assets | $536.47M | $567.67M | $598.97M | $633.56M | $633.56M |
| Non-Current Deferred Assets | $25.44M | $25.57M | $25.65M | $25.89M | $25.89M |
| Other Non-Current Assets | $69.16M | $63.44M | $63.50M | $53.46M | $53.46M |
| Total Liabilities | $1.75B | $1.82B | $1.90B | $1.93B | $1.93B |
| Total Current Liabilities | $514.63M | $498.36M | $517.90M | $498.86M | $498.86M |
| Payables | $153.08M | $157.13M | $184.58M | $164.77M | $164.77M |
| -Accounts Payable | $142.99M | $149.17M | $173.98M | $154.37M | $154.37M |
| -Total Tax Payable | $10.09M | $7.96M | $10.60M | $10.40M | $10.40M |
| Current Accrued Expenses | $201.69M | $200.65M | $204.43M | $196.10M | $196.10M |
| Short-Term Debt and Capital Lease Obligation | $18.75M | $18.75M | $18.75M | $18.75M | $18.75M |
| -Current Debt | $18.75M | $18.75M | $18.75M | $18.75M | $18.75M |
| Current Provisions | $26.30M | $25.67M | $25.08M | $24.60M | $24.60M |
| Current Deferred Liabilities | $63.37M | $54.37M | $60.66M | $33.84M | $33.84M |
| Total Non-Current Liabilities | $1.24B | $1.32B | $1.38B | $1.43B | $1.43B |
| Long Term Accounts Payable and Other Payables | $26.92M | $25.40M | $25.26M | $34.61M | $34.61M |
| Long Term Debt and Capital Lease Obligation | $1.17B | $1.25B | $1.31B | $1.31B | $1.31B |
| -Long Term Debt | $1.13B | $1.21B | $1.26B | $1.27B | $1.27B |
| -Long Term Capital Lease Obligation | $39.87M | $40.37M | $45.23M | $47.68M | $47.68M |
| Non-Current Deferred Liabilities | $8.76M | $12.23M | $14.51M | $37.76M | $37.76M |
| Other Non-Current Liabilities | $29.10M | $30.62M | $37.11M | $41.86M | $41.86M |
| Total Equity | $2.19B | $2.15B | $2.11B | $2.12B | $2.12B |
| Stockholders' Equity | $2.19B | $2.15B | $2.11B | $2.12B | $2.12B |
| Capital Stock | $2.52M | $2.52M | $2.52M | $2.47M | $2.47M |
| -Common Stock | $2.52M | $2.52M | $2.52M | $2.47M | $2.47M |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $1.49B | $1.48B | $1.47B | $1.47B | $1.47B |
| Retained Earnings | $766.96M | $740.11M | $721.02M | $690.89M | $690.89M |
| Less: Treasury Stock | -$23.04M | -$23.42M | -$25.18M | -$22,000.00 | -$22,000.00 |
| Gains/Losses Not Affecting Retained Earnings | -$42.17M | -$43.34M | -$51.90M | -$34.63M | -$34.63M |
| Financial Assets | – | – | – | $3.82M | $3.82M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $99.59M | $80.15M | $38.91M | $179.85M | $60.60M |
| Net cash flow from continuing operations | $99.59M | $80.18M | $38.88M | $179.85M | $60.60M |
| Net Income from Continuing Operations | $26.85M | $19.09M | $30.13M | $732,000.00 | -$15.73M |
| Gain/Loss from Continuing Operations | -$9,000.00 | -$1.17M | $743,000.00 | -$35.24M | $7.64M |
| Depreciation & Depletion & Amortization | $49.59M | $49.64M | $50.00M | $200.74M | $50.83M |
| Other Non-Cash Items | $11.03M | $15.22M | $7.96M | $47.90M | $10.83M |
| Change in Working Capital | $260,000.00 | -$14.50M | -$63.94M | -$90.04M | -$6.84M |
| -Change in Receivables | -$21.99M | $16.58M | -$24.15M | $8.88M | $4.93M |
| -Change in Inventory | -$2.31M | -$1.46M | $6.09M | -$26.25M | $9.96M |
| -Change in Prepaid Assets | $7.75M | -$2.11M | -$14.35M | -$10.96M | -$6.24M |
| -Change in Payables and Accrued Expense | $12.89M | -$21.11M | $10.30M | -$29.97M | -$24.41M |
| -Change in Other Current Assets | $1.20M | -$573,000.00 | -$2.36M | -$6.98M | $167,000.00 |
| -Change In Other Working Capital | $2.71M | -$5.82M | -$39.48M | -$24.76M | $8.74M |
| Net cash flow from investing | -$13.93M | -$20.14M | -$11.21M | $122.23M | -$18.39M |
| Net Cash Flow from Continuing Investing Activities | -$13.93M | -$20.14M | -$11.21M | $122.23M | -$18.39M |
| Net PPE Purchase and Sale | -$16.19M | -$18.51M | -$11.30M | -$88.04M | -$24.65M |
| Net Intangibles Purchase and Sale | -$1.69M | -$1.65M | -$1.91M | -$8.97M | -$1.76M |
| Net Business Purchase and Sale | $3.93M | $0.00 | $2.00M | $211.19M | $0.00 |
| Net Other Investing Changes | $17,000.00 | $21,000.00 | $1,000.00 | $8.06M | $8.02M |
| Financing Cash Flow | -$80.97M | -$50.24M | -$44.12M | -$311.53M | -$34.49M |
| Net Cash Flow from Continuing Financing Activities | -$80.97M | -$50.24M | -$44.12M | -$311.53M | -$34.49M |
| Net Issuance Payments Of Debt | -$80.67M | -$50.64M | -$5.35M | -$304.49M | -$30.19M |
| Proceeds from Stock Option Exercised | $0.00 | $490,000.00 | $0.00 | $6.11M | $134,000.00 |
| Net Other Financing Charges | -$304,000.00 | -$86,000.00 | -$38.78M | -$13.15M | -$4.43M |
| Ending Cash Balance | $301.78M | $298.30M | $288.33M | $307.96M | $307.96M |
| Net Change in Cash | $4.69M | $9.78M | -$16.42M | -$9.45M | $7.72M |
| Beginning Cash Balance | $298.30M | $288.33M | $307.96M | $308.57M | $299.73M |
| Effect of Exchange Rate Changes | -$1.20M | $191,000.00 | -$3.21M | $8.85M | $508,000.00 |
| Free Cash Flow | $81.71M | $59.99M | $25.70M | $82.83M | $34.19M |
| Net Investment Purchase and Sale | – | – | – | $0.00 | $0.00 |
No comments yet — be the first to weigh in on ICUI.
Sign in to join the discussion.